McKesson Ventures, LLC 4
4 · Augmedix, Inc. · Filed Nov 1, 2021
Insider Transaction Report
Form 4
Augmedix, Inc.AUGX
Transactions
- Purchase
Common Stock
[F1]2021-10-28$4.00/sh+87,500$350,000→ 4,022,606 total
Footnotes (1)
- [F1]These securities are held of record by McKesson Ventures LLC ("McKesson"). Jennifer M. Carter, a member of the Issuer's board of directors, is an executive vice president and chief strategy and business development officer at McKesson. As a result, McKesson is a director by deputization for Section 16 purposes.
Signature
McKesson Ventures, LLC by: /s/ Jennifer Carter, Executive Vice President|2021-11-01